News | July 16, 2019
The Know Now Testing Program is an initiative from Novartis in collaboration with Quest Diagnostics that offers genetic mutation testing at no cost for all patients with stage III or stage IV melanoma. Nearly half of all advanced...
News | June 21, 2019
A new clinical study confirms the clinical utility of the DermTech’s pigmented lesion assay (PLA)in the early detection of melanoma. The PLA is a non-invasive test that uses molecular gene expression to identify...
News | June 17, 2019
A new eco-friendly, gel-based sunscreen line from Sonrei, LLC is now available. “Crafted for every kind,” Sonrei is driven by a commitment of bringing to market a translucent broad-spectrum SPF with environmental principles at...
Skin Cancer Foundation president Deborah Sarnoff, MD talks about the Foundation's accomplishments, its current focus, and future goals. Founded in 1979, the foundation has helped educate the public on skin cancer risk and supports dermatologists in practice.
News | May 8, 2019
Sensus Healthcare, Inc.has been awarded a group purchasing agreement for Brachytherapy Products with Premier. Effective August 1, 2019, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and...
DermWireTV: Skin Cancer Foundation’s Big See, Cosmetic Consumer Insights, Cosmetic Bootcamp Recap
Martin Azzam, BS/BA; Sally Osborne-Barone, BS; and Whitney Hovenic, MD/MPH
What your patients—and you—should know about the latest developments around sunscreens.
Jonathan Wolfe, MD
A test analyzes 31 specific genes in excised tumors to predict risk for metastasis.
Brook Brouha, MD, PhD
Elizabeth Veasey, MD
Skin Cancer Foundation president Deborah Sarnoff, MD talks about the Foundation's accomplishments, its current focus, and future goals. Founded in...
Deborah Sarnoff, MD
ISDIN Teams Up with The Claire Marie Foundation And The Ulman Foundation For Skin Cancer Awareness Month